Janus kinase inhibitor for anti-transcription intermediary factor 1-Î³ positive cancer-associated dermatomyositis.

Wu, Wanlong; Chen, Jinju; Zhu, Linling; Sha, Yaping; Wang, Kaiwen; Zhao, Jiangfeng; Ye, Chunhua; Ye, Shuang

Wu, Wanlong; Chen, Jinju; Zhu, Linling; Sha, Yaping; Wang, Kaiwen; Zhao, Jiangfeng; Ye, Chunhua; Ye, Shuang.

Afiliação

Wu W; Department of Rheumatology.
Chen J; Jiading Branch, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhu L; Department of Rheumatology.
Sha Y; Department of Rheumatology.
Wang K; Department of Rheumatology.
Zhao J; Department of Rheumatology.
Ye C; Department of Rheumatology.
Ye S; Jiading Branch, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Br J Dermatol ; 190(2): 285-287, 2024 Jan 23.

Article em En | MEDLINE | ID: mdl-37850872

Assuntos

Dermatomiosite; Inibidores de Janus Quinases; Neoplasias; Humanos; Análise de Mediação; Autoanticorpos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatomiosite / Inibidores de Janus Quinases / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google